Index
RUT
Market Cap
5.44B
Enterprise Value
5.81B
Income
145.56M
Sales
1.58B
Book/sh
28.13
Cash/sh
7.55
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
7500
IPO
May 14, 1990
P/E
37.58
Forward P/E
19.77
PEG
2.19
P/S
3.45
P/B
3.24
P/C
12.07
P/FCF
26.79
EV/EBITDA
17.28
EV/Sales
3.68
Quick Ratio
2.79
Current Ratio
4.20
Debt/Eq
0.49
LT Debt/Eq
0.48
Option/Short
Yes / Yes
EPS (ttm)
2.43
EPS next Y
4.61
EPS next Q
1.04
EPS this Y
12.33%
EPS next Y
7.20%
EPS next 5Y
9.02%
EPS past 3/5Y
18.04% -
Sales past 3/5Y
9.70% 9.46%
EPS Y/Y TTM
20.67%
Sales Y/Y TTM
10.51%
EPS Q/Q
20.30%
Sales Q/Q
9.83%
Insider Own
2.60%
Insider Trans
-1.56%
Inst Own
105.30%
Inst Trans
3.85%
ROA
5.34%
ROE
9.19%
ROIC
5.85%
Gross Margin
49.43%
Oper. Margin
12.69%
Profit Margin
9.21%
SMA20
4.26%
SMA50
3.22%
SMA200
18.80%
Trades
Shs Outstand
59.71M
Shs Float
58.16M
52W High
94.75 -3.77%
52W Low
59.74 52.63%
Volatility
2.53% 2.31%
ATR (14)
2.16
RSI (14)
62.71
Beta
0.56
Rel Volume
0.87
Avg Volume
788.06K
Volume
688,873
Perf Week
3.45%
Perf Month
6.66%
Perf Quarter
24.72%
Perf Half Y
34.35%
Perf YTD
3.45%
Perf Year
9.58%
Perf 3Y
40.64%
Perf 5Y
29.72%
Perf 10Y
277.56%
Prev Close
89.96
Price
91.18
Change %
1.36%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-26 Downgrade Wells Fargo
Overweight → Equal Weight
$78
Feb-06-26 Initiated BTIG Research
Buy
$107
Mar-28-25 Initiated JP Morgan
Overweight
$120
Dec-11-24 Upgrade Wells Fargo
Equal Weight → Overweight
$103 → $120
Jun-28-24 Initiated Robert W. Baird
Outperform
$96
Apr-11-24 Initiated CL King
Buy
$88
Feb-07-24 Initiated BofA Securities
Neutral
$87
Dec-21-23 Upgrade Canaccord Genuity
Hold → Buy
$100
Dec-20-22 Downgrade Canaccord Genuity
Buy → Hold
$73 → $72
Jan-05-21 Upgrade Needham
Hold → Buy
$65
Sep-28-20 Upgrade Wells Fargo
Underweight → Equal Weight
$42
Feb-25-20 Downgrade Barrington Research
Outperform → Mkt Perform
Feb-03-20 Upgrade Raymond James
Mkt Perform → Outperform
$43
Dec-12-19 Downgrade Wells Fargo
Market Perform → Underperform
$26
Sep-24-19 Initiated Oppenheimer
Outperform
Sep-10-19 Downgrade Raymond James
Outperform → Mkt Perform
Jul-26-19 Downgrade Wells Fargo
Outperform → Market Perform
Jul-26-19 Downgrade Needham
Buy → Hold
Oct-02-18 Reiterated Needham
Buy
$67 → $73
Aug-07-18 Downgrade BofA/Merrill
Buy → Underperform
Show Previous Ratings
Oct-06-26 04:30PM
Sep-04-26 09:25AM
Aug-19-26 04:05PM
Aug-05-26 12:00PM
Jul-31-26 08:30AM
01:05AM
Loading…
01:05AM
Jul-30-26 04:33PM
04:05PM
Jul-02-26 04:05PM
May-19-26 09:15AM
May-08-26 09:25AM
May-01-26 03:18AM
Apr-30-26 08:48PM
04:50PM
04:05PM
06:00PM
Loading…
Apr-02-26 06:00PM
07:14AM
Apr-01-26 10:27PM
09:15AM
Mar-24-26 08:30AM
Mar-16-26 09:25AM
Mar-04-26 10:33PM
Mar-02-26 11:40AM
09:40AM
Feb-27-26 09:45AM
Feb-26-26 08:00AM
Feb-25-26 11:42PM
01:55PM
12:08AM
12:04AM
08:00PM
Loading…
Feb-24-26 08:00PM
07:30PM
04:54PM
(Associated Press Finance)
04:43PM
04:05PM
Feb-22-26 10:09PM
Feb-17-26 09:19AM
Feb-16-26 08:54AM
Feb-13-26 03:51PM
09:39AM
Feb-12-26 01:07PM
11:40AM
07:10AM
Feb-11-26 09:55AM
Feb-10-26 01:30PM
11:22AM
08:57AM
Feb-09-26 10:24AM
08:02AM
Feb-06-26 09:45AM
09:41AM
08:07AM
Feb-05-26 10:32PM
10:45AM
Feb-04-26 05:25PM
01:55PM
10:23AM
08:47AM
Feb-03-26 11:38AM
Feb-02-26 09:37AM
09:13AM
Jan-29-26 08:02AM
Jan-28-26 07:46AM
07:43AM
07:27AM
07:26AM
Jan-27-26 12:19PM
07:54AM
Jan-26-26 12:10PM
Jan-22-26 12:27PM
Jan-21-26 10:06AM
Jan-08-26 04:05PM
Dec-26-25 11:40AM
Dec-23-25 02:09PM
09:00AM
Dec-18-25 09:50AM
Dec-11-25 11:01PM
Dec-10-25 11:40AM
Nov-24-25 11:40AM
Nov-21-25 06:50PM
12:00PM
Nov-19-25 09:50AM
Nov-13-25 04:05PM
Nov-07-25 11:40AM
Nov-06-25 12:37AM
Nov-05-25 09:00AM
Nov-03-25 09:25AM
Oct-31-25 02:11PM
02:01PM
08:40AM
Oct-30-25 11:04PM
07:30PM
06:20PM
05:24PM
(Associated Press Finance)
05:10PM
04:05PM
Oct-29-25 09:31AM
08:23AM
Oct-28-25 11:17PM
Oct-24-25 01:49PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Peterson Neil W. CHIEF OPERATING OFFICER Aug 24 '26 Sale 90.45 7,500 678,360 18,051 Aug 25 04:43 PM NEIL W PETERSON Officer Aug 24 '26 Proposed Sale 90.45 7,500 678,360 Aug 24 04:07 PM Peterson Neil W. CHIEF OPERATING OFFICER Aug 04 '26 Sale 85.00 21,449 1,823,165 25,551 Aug 05 01:22 PM NEIL W PETERSON Officer Aug 04 '26 Proposed Sale 85.00 21,449 1,823,165 Aug 04 04:10 PM Gunderson Thomas J. Director May 20 '26 Option Exercise 52.17 21,250 1,108,612 60,741 May 21 09:10 AM Smith Christian Adam Chief Commercial Officer May 11 '26 Buy 61.00 1,626 99,186 2,220 May 13 01:19 PM Ward Lynne N. Director May 07 '26 Sale 62.61 5,000 313,035 7,809 May 11 01:04 PM Lloyd Brian G. CHIEF LEGAL OFFICER, SECRETARY May 07 '26 Buy 62.62 2,000 125,250 2,000 May 11 01:03 PM Aronson Martha Goldberg President and CEO May 06 '26 Buy 60.44 2,000 120,880 49,792 May 07 04:12 PM LYNNE WARD Director May 07 '26 Proposed Sale 62.61 5,000 313,036 May 07 04:11 PM Parra Raul Jr. CFO AND TREASURER May 06 '26 Buy 61.01 1,500 91,515 58,843 May 07 04:09 PM Voigt Michel J. CHIEF HUMAN RESOURCES OFFICER May 05 '26 Buy 60.65 2,250 136,462 2,265 May 07 04:07 PM Peterson Neil W. CHIEF OPERATING OFFICER Jan 06 '26 Option Exercise 54.40 5,000 272,000 33,369 Jan 08 12:57 PM Peterson Neil W. CHIEF OPERATING OFFICER Jan 06 '26 Sale 90.00 5,000 450,000 28,369 Jan 08 12:57 PM NEIL W PETERSON Officer Jan 06 '26 Proposed Sale 90.00 5,000 450,000 Jan 06 04:02 PM Lampropoulos Fred P. Executive Chairman Nov 25 '25 Sale 88.04 10,000 880,377 1,019,955 Nov 26 03:22 PM FRED LAMPROPOULOS Director Nov 25 '25 Proposed Sale 88.04 10,000 880,377 Nov 25 04:27 PM Lampropoulos Fred P. Executive Chairman Nov 21 '25 Sale 87.31 25,000 2,182,750 1,029,955 Nov 24 06:00 PM FRED LAMPROPOULOS Director Nov 21 '25 Proposed Sale 87.31 25,000 2,182,631 Nov 21 04:06 PM Lampropoulos Fred P. Executive Chairman Nov 20 '25 Sale 85.13 20,000 1,702,650 1,054,955 Nov 21 10:47 AM Lampropoulos Fred P. Executive Chairman Nov 18 '25 Sale 84.83 5,000 424,130 1,074,955 Nov 20 04:37 PM FRED LAMPROPOULOS Director Nov 20 '25 Proposed Sale 85.13 20,000 1,702,650 Nov 20 04:18 PM FRED LAMPROPOULOS Director Nov 18 '25 Proposed Sale 84.83 5,000 424,130 Nov 18 04:19 PM
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
President Ms. Martha Goldberg Aronson
CPA Mr. Raul Parra Jr.
Chief Legal Officer & Corporate Secretary Mr. Brian G. Lloyd J.D.
Chief Human Resources Officer Mr. Michel J. Voigt
Senior Advisor Mr. Neil W. Peterson
M